Business Wire

Xsolla Founder Shurick Agapitov Releases Once Upon Tomorrow Fortnite Island: A Groundbreaking Immersive Experience That Brings the Novel's Universe to Life

12.12.2024 15:00:00 CET | Business Wire | Press release

Share

High-Octane Parkour Challenges Meet Story-Driven Gameplay in a New Fortnite Creative Map Inspired by Once Upon Tomorrow

Shurick Agapitov, founder of Xsolla and visionary in the gaming industry, proudly announces the Once Upon Tomorrow Fortnite Island release. This immersive Fortnite Creative map transports players into the rich narrative world of his novel. The innovative experience, developed in Unreal Editor for Fortnite (UEFN), masterfully combines high-speed parkour challenges with deep thematic elements from Once Upon Tomorrow, inviting players to test their skills while journeying through a visually captivating landscape that embodies the resilience and adventure of the book’s characters.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241212923969/en/

(Graphic: Xsolla)

“Once Upon Tomorrow in Fortnite Creative is our way of expanding the reach and depth of the novel, offering players an interactive journey that challenges both their skills and their understanding of the story’s themes,” said Shurick Agapitov, Founder of Xsolla. “We designed this map to captivate players who crave a good challenge and to immerse them in a world that’s visually rich and deeply inspired by the book. It’s an adventure that leverages UEFN’s technical strengths to elevate storytelling in Fortnite in a way that truly transforms the game experience.”

Designed to push the boundaries of Fortnite Creative, Once Upon Tomorrow offers players a dynamic, narrative-driven parkour adventure set within a meticulously crafted environment inspired by Agapitov’s book and vision. Each course presents a series of agility-based challenges that require players to sprint, leap, and climb with precision and speed, all while immersed in a world filled with visual cues that echo the themes of endurance and discovery central to the book. Agapitov has created an experience beyond traditional parkour maps by weaving gameplay with storytelling, delivering both exhilarating gameplay and a meaningful connection to the novel’s world.

Once Upon Tomorrow is a project within Fortnite Creative, seamlessly blending high-stakes parkour with narrative depth. The map is a testament to what can be achieved using UEFN, offering an engaging and multi-layered experience that appeals to Fortnite’s extensive player base and fans of novel and narrative-rich gaming experiences. Every aspect of the map—from its intense gameplay mechanics to its immersive, atmospheric design—has been crafted to set a new standard in Fortnite Creative.

For more information about Once Upon Tomorrow and its immersive Fortnite Creative experience, please visit xsolla.blog/outf

About Shurick Agapitov

Shurick Agapitov is the visionary founder of Xsolla, a globally recognized leader in video game commerce. Known for his contributions to gaming, Web3, and the metaverse, Agapitov has driven Xsolla to become a vital resource for game developers and publishers worldwide. His dedication to enhancing digital and interactive experiences is reflected in the launch of Once Upon Tomorrow, extending his vision beyond the page to the dynamic world of Fortnite Creative.

About Xsolla

Xsolla is a global video game commerce company with a robust and powerful set of tools and services designed specifically for the industry. Since its founding in 2005, Xsolla has helped thousands of game developers and publishers of all sizes fund, market, launch, and monetize their games globally and across multiple platforms. As an innovative leader in game commerce, Xsolla’s mission is to solve the inherent complexities of global distribution, marketing, and monetization to help our partners reach more geographies, generate more revenue, and create relationships with gamers worldwide. Headquartered and incorporated in Los Angeles, California, with offices in London, Berlin, Seoul, Beijing, Kuala Lumpur, Raleigh, Tokyo, Montreal, and cities around the world, Xsolla supports leading gaming partners such as Valve, Twitch, Epic Games, Take-Two, KRAFTON, Nexters, NetEase, Playstudios, Playrix, miHoYo, among others.

For additional information and to learn more, please visit xsolla.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20241212923969/en/

null

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Three Chugai Researchers Behind the Discovery of Hemlibra for Hemophilia A Receive Prestigious U.S. Lasker Award, One of the World’s Most Respected Scientific Honors9.9.2026 15:45:00 CEST | Press release

- Recognized for the invention of a bispecific antibody that transformed treatment paradigm through an unconventional approach – Recognized for realizing a novel drug discovery concept in which a bispecific antibody replaces the function of coagulation Factor VIII, which is deficient in hemophilia A. Provided improved convenience through prolonged activity and subcutaneous administration, and provided a treatment option regardless of factor VIII inhibitors, thereby helping address unmet medical needs in hemophilia A. First time since the establishment of the Lasker Foundation in 1945 that three Japanese researchers have received the award simultaneously. Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) today announced that Dr. Kunihiro Hattori (former Senior Fellow of Chugai), Dr. Takehisa Kitazawa (Deputy Head of Research Division, Chugai), and Dr. Tomoyuki Igawa (Head of Research Division, Chugai), who led the creation of Hemlibra (emicizumab), a treatment for hemophilia A, have been aw

AMCS Appoints Richard Humphrey as Chief Product and Technology Officer9.9.2026 15:00:00 CEST | Press release

Industrial software executive to lead global product strategy and accelerate AI innovation AMCS, a leading technology provider for the waste and recycling industry, today announced the appointment of Richard Humphrey as Chief Product and Technology Officer. Based in Boston, Humphrey will lead the company’s global product organisation. Humphrey brings more than 25 years of experience developing software for construction and other complex industrial environments. He joins AMCS as the company deepens its focus on waste and recycling and expands the role of AI across its platform. Most recently, Humphrey served as Chief Product and Technology Officer at Contruent, where he led product strategy for a construction cost-management platform used on major capital programmes. He previously held vice president roles at Bentley Systems and B2W Software. Earlier in his career, he spent more than a decade at Autodesk, where he led its Civil Design and Construction software business as Senior Directo

BBH Launches a New Technology Business, Braid, Solving for Intelligent Data Transformation9.9.2026 14:45:00 CEST | Press release

Braid’s agentic AI platform is purpose-built for financial services firms who need to transform, connect, and manage their data with confidence Brown Brothers Harriman (BBH) today announced the launch of a new technology affiliate, Braid LLC, focused on solving enterprise data transformation for financial services. Braid offers an AI-native data transformation platform that gives firms a scale solution to transform, connect, and manage their data with confidence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260909294398/en/ Braid empowers teams to build, automate, and oversee reliable production-grade data transformations in a fraction of the time typically required today. Instead of requiring engineers to build data automations, Braid allows business users to describe their needs in natural language that AI agents use to build intelligent data transformations that are transparent and fully auditable. Braid’s enterprise-gr

LTM Collaborates with IBM and Red Hat on Lightwell to Advance AI-Driven Open-Source Software Remediation9.9.2026 14:30:00 CEST | Press release

Strengthens software supply chains by helping enterprises transform vulnerability discovery into scalable remediation outcomes LTM, the Business Creativity partner to the world's largest enterprises, today announced that it has collaborated with IBM and Red Hat on Lightwell to help enterprises safeguard the open-source software supply chain through AI-driven vulnerability remediation. As AI accelerates the discovery of software vulnerabilities, organizations must move beyond detection-focused approaches and adopt enterprise-scale remediation strategies that enable rapid risk mitigation without disrupting business-critical applications. Lightwell’s approach of delivering validated fixes for production environments aligns with LTM's aim of helping customers build secure, resilient, and operationally efficient software supply chains. By combining AI-powered remediation capabilities with enterprise-grade validation and deployment support, Lightwell aims to help organizations address securi

New England Journal of Medicine Publishes Data from Phase 3 Studies Demonstrating Oveporexton (ORZEYFUL) Improved the Full Range of Narcolepsy Type 1 Symptoms and Quality of Life9.9.2026 14:24:00 CEST | Press release

Data Demonstrated Significant and Clinically Meaningful Improvements with the Potential to Redefine Narcolepsy Type 1 (NT1) Care Beyond Individual Symptoms Oveporexton was Generally Well-Tolerated with Safety Profile Consistent with Previous Clinical Studies Oveporexton is the First and Only Approved Orexin Agonist Designed to Treat the Underlying Cause of NT1 and is Now Approved in the U.S., China and Japan, with Additional Regulatory Submissions Underway Takeda (TSE:4502/NYSE:TAK) announced that the New England Journal of Medicine published results from two Phase 3 studies evaluating oveporexton (ORZEYFUL), an oral orexin receptor 2 (OX2R) agonist, in people with narcolepsy type 1 (NT1).1 Oveporexton is the first and only medicine to treat the underlying cause of NT1. "People living with narcolepsy type 1 face persistent symptoms across the day and night, which can impact many aspects of daily life,” said Emmanuel Mignot, M.D., Ph.D., principal investigator for the FirstLight (TAK-86

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye